Selbyville, Delaware, Oct. 04, 2023 (GLOBE NEWSWIRE) --
Downstream Processing Market size is expected to be worth USD 64 billion by 2032. The industry is experiencing robust development, driven by the burgeoning biopharmaceutical industry, increasing demand for biopharmaceutical products, and advancements in purification techniques.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/6479
Biopharmaceuticals, such as monoclonal antibodies, recombinant proteins, and vaccines, have gained substantial prominence in recent years. The increasing prevalence of chronic diseases and the demand for personalized medicines have propelled the production of biopharmaceuticals, consequently driving the need for efficient downstream processing. Additionally, there are technological advancements in the techniques. The adoption of single-use technologies, continuous processing, and automation has enhanced productivity and reduced production costs. This, in turn, has attracted biopharmaceutical manufacturers towards upgrading their downstream processing capabilities.
Wider usage of solid-liquid separation technique in biopharma sector
The solid-liquid separation technique segment is gaining momentum in the downstream processing market, owing its widespread usage in the isolation and purification of biopharmaceutical products. Various techniques, including centrifugation, filtration, and chromatography, are employed to separate solids from liquids, based on the application. For instance, centrifugation is particularly useful in large-scale bioprocessing for initial clarification steps, while filtration is critical for achieving the desired purity of biopharmaceutical products. Chromatography is effective for achieving high-purity separations and is extensively employed in the pharmaceutical and biotechnology industries. The need for attaining high purity and different concentration levels in biopharma production.
Diverse applications of filters to promote product uptake
The filters segment of downstream processing market is poised to witnessing significant demand during 2023-2032, as the product ensures the quality and purity of biopharmaceutical products. Depending on the type, the filters can be used for diverse requirements. Membrane filters, with their precise pore size and scalability, are indispensable for clarifying and sterilizing biopharmaceutical solutions. Meanwhile, depth filters, with their gradient-density structure, are well-suited for capturing particles and colloids. They are often used in combination with other filtration methods to achieve optimal results in downstream processing.
Rising cases of diabetes to boost product demand for insulin application
The downstream processing market share from insulin application is estimated to grow at a rapid rate through 2032, driven by the vitality of insulin in managing diabetes. Downstream processing techniques play a crucial role in the purification and isolation of insulin, ensuring that the final product is not only of high purity but also safe and efficacious for therapeutic use. The global prevalence of diabetes continues to rise, placing an ever-increasing demand for high-quality insulin products. Moreover, ongoing R&D efforts that aim to enhance insulin formulations and delivery methods further drive the need for advanced downstream processing techniques.
Booming biopharmaceutical vertical to support APAC market growth
Asia Pacific downstream processing market held a notable revenue share in 2022 and is touted to display impressive expansion trends over the forecast period, owing to the rapid expansion of the biopharmaceutical sector in countries like China and India. The availability of skilled labor, cost-effective manufacturing, and supportive government initiatives are favoring the progress of biopharmaceutical manufacturing in the APAC region. The rising occurrence of lifestyle ailments, and huge geriatric population who are prone to these diseases is augmenting the focus on ensuring availability of advanced therapies.
Request for Report Customization @ https://www.gminsights.com/roc/6479
Prominent players in the downstream processing market are Thermo Fisher Scientific Inc., Sartorius Stedim Biotech S.A, Merck and Co. Inc., Boehringer Ingelheim International GmbH, 3M Company, Lonza Group Ltd., Danaher Corporation, Eppendorf AG, GE Healthcare, and Repligen Corporation.
Partial Table of Contents (ToC) of the report:
Chapter 3 Downstream Processing Industry Insights
3.1 Industry landscape, 2018 – 2032 (USD Million)
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing demand for biopharmaceuticals
3.2.1.2 Increasing R&D expenditure in biopharmaceutical industries
3.2.1.3 Increasing advancements and adoption of single use technologies
3.2.1.4 Rise in the prominence of contract manufacturing organizations (CMOs)
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of instruments and purification
3.2.2.2 Dearth of skilled personnel
3.3 Growth potential analysis
3.3.1 By technique
3.3.2 By product
3.3.3 By application
3.3.4 By end-user
3.4 COVID-19 impact analysis
3.5 Regulatory landscape
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Global company market share analysis, 2022
4.4 Competitive positioning matrix, 2022
4.5 Strategic dashboard, 2022
Browse Our Reports Store - GMIPulse @ https://www.gminsights.com/gmipulse
About Global Market Insights
Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.
